Adeno Associated Virus Vector Manufacturing Market Demand, Size and Competitive Analysis | TechSci Research

Global Adeno Associated Virus Vector Manufacturing Market was valued at USD 985.85 Million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 12.30% through 2029. <table><tr><td>Pages</td><td>180</td></tr> <tr><td>Market Size</td><td>2023: USD 985.85 Million</td></tr> <tr><td>Forecast Market Size</td><td>2029: USD 1981.70 Million</td></tr> <tr><td>CAGR</td><td>2024-2029: 12.30%</td></tr> <tr><td>Fastest Growing Segment</td><td>Clinical</td></tr> <tr><td>Largest Market</td><td>North America</td></tr> <tr><td>Key Players</td><td>1.F. Hoffmann-La Roche Ltd2.Charles River Laboratories International, Inc.3.Oxford Biomedica PLC4.WuXi AppTec5.Yposkesi, Inc.6.Sarepta Therapeutics, Inc.7.Pfizer Inc.8.Genezen9.Creative Biogene10.ProBio</td></tr> </table>

全球腺病毒载体制造市场在2023年达到了9.85亿美元的规模，预计在预测期内将实现令人瞩目的增长，复合年增长率(CAGR)预计将达到12.30%，并于2029年达到19.81亿美元。

<table>
<tr>
<td>页数</td>
<td>180</td>
</tr>
<tr>
<td>市场规模</td>
<td>2023年：9.85亿美元</td>
</tr>
<tr>
<td>预测市场规模</td>
<td>2029年：19.81亿美元</td>
</tr>
<tr>
<td>复合年增长率(CAGR)</td>
<td>2024-2029年：12.30%</td>
</tr>
<tr>
<td>增长最快的细分市场</td>
<td>临床</td>
</tr>
<tr>
<td>最大市场</td>
<td>北美</td>
</tr>
<tr>
<td>主要参与者</td>
<td>1. Hoffmann-La Roche Ltd 2. Charles River Laboratories International, Inc. 3. Oxford Biomedica PLC 4. WuXi AppTec 5. Yposkesi, Inc. 6. Sarepta Therapeutics, Inc. 7. Pfizer Inc. 8. Genezen 9. Creative Biogene 10. ProBio</td>
</tr>
</table>